Development
MetLife, Inc.
MET
$79.93
$1.371.74%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.58B | 2.55B | 3.22B | 3.73B | 5.28B |
| Total Depreciation and Amortization | 718.00M | 669.00M | 672.00M | 673.00M | 673.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.98B | 5.52B | 5.68B | 6.53B | 4.99B |
| Change in Net Operating Assets | 1.45B | 2.10B | 2.10B | 2.10B | 2.10B |
| Cash from Operations | 13.72B | 10.84B | 11.68B | 13.03B | 13.04B |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 0.00 | 0.00 | 590.00M | 590.00M |
| Other Investing Activities | -10.25B | -11.02B | -12.16B | -4.29B | -3.21B |
| Cash from Investing | -10.25B | -11.02B | -12.16B | -3.70B | -2.62B |
| Total Debt Issued | 2.67B | 2.34B | 2.28B | 2.01B | 1.01B |
| Total Debt Repaid | -5.24B | -8.89B | -6.70B | -11.60B | -10.87B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.10B | -2.84B | -2.72B | -3.17B | -3.33B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.76B | -1.77B | -1.77B | -1.78B | -1.78B |
| Other Financing Activities | 4.50B | 3.93B | 4.27B | 425.00M | 5.01B |
| Cash from Financing | -2.94B | -7.23B | -4.64B | -14.11B | -9.95B |
| Foreign Exchange rate Adjustments | -91.00M | 123.00M | -6.00M | -279.00M | -397.00M |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 23.00M | 69.00M |
| Net Change in Cash | 444.00M | -7.29B | -5.13B | -5.03B | 148.00M |